e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Morphological and functional imaging in obstructive airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CT densitometry as a predictor of pulmonary function in lung cancer patients
F. Moloney, S. McWilliams, M. Kennedy, M. Maher, M. Henry (Cork, Ireland)
Source:
Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease
Session:
Morphological and functional imaging in obstructive airway disease
Session type:
Poster Discussion
Number:
4606
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Moloney, S. McWilliams, M. Kennedy, M. Maher, M. Henry (Cork, Ireland). CT densitometry as a predictor of pulmonary function in lung cancer patients. Eur Respir J 2011; 38: Suppl. 55, 4606
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Correlation of different thresholds in CT lung densitometry and pulmonary function tests in stable COPD patients
Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema
Year: 2007
The value of lung perfusion scintigraphy in the prediction of postoperative function in lung cancer
Source: Annual Congress 2004 - Assessment of lung function before resection of lung cancer
Year: 2004
Factors influencing the decline in lung density in a Danish lung cancer screening cohort
Source: Eur Respir J 2012; 40: 1142-1148
Year: 2012
Correlation of CT estimated lung volumes with pulmonary function tests in COPD patients
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
CT quantification of lung lesions as a prognostic factor for severe lung damage in COVID-19 patients
Source: Virtual Congress 2021 – COVID - 19
Year: 2021
Accuracy of the calculated estimated postoperative pulmonary function (CEPPF) in lung cancer patients
Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Year: 2007
Pulmonary function testing in patients with lung cancer
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012
Lung cancer in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 1216-1219
Year: 2001
Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening
Source: Eur Respir J, 58 (3) 2003386; 10.1183/13993003.03386-2020
Year: 2021
Factors associated with delayed recovery to predicted FEV1 calculated with perfusion scan in non-small-cell lung cancer patients after lobectomy
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Pulmonary hypertension is a common complication of COPD, but CT scanning and lung function tests do not identify patients at risk
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010
Lung emphysema detected on low dose computed tomography of the chest is associated with a higher risk for lung cancer
Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema
Year: 2007
Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes
Source: Eur Respir J 2010; 35: 146-151
Year: 2010
MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension.
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
CT scans from CF patients screened for lung transplant; the severe advanced lung disease (SALD) CT scoring system and correlation with survival
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007
The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005
Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers
Source: Eur Respir J, 56 (5) 2000177; 10.1183/13993003.00177-2020
Year: 2020
Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007
Pulmonary metastases in patients with breast cancer: thin-section CT findings in 29 patients
Source: Eur Respir J 2006; 28: Suppl. 50, 776s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept